ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 520

Genetic Associations to Germinal Centre Formation in Primary Sjögren’s Syndrome

Tove Ragna Reksten1, Malin V. Jonsson2, Roland Jonsson1, Gunnel Nordmark3 and The Swedish-Norwegian Sjögren's syndrome Network4, 1Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway, 2Department of Clinical Dentistry - Section for Oral and Maxillofacial Radiology, University of Bergen, Bergen, Norway, 3Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 4Bergen

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Cytokines and genomics

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Primary Sjögren’s syndrome (pSS) is an autoimmune rheumatic disease mainly affecting the salivary and lacrimal glands causing xerostomia and keratoconjunctivitis sicca. Focal mononuclear cell inflammation in the form of germinal center-like structures (GC) is found in the minor salivary glands of 20-25 % of patients. We have previously shown that GC+ pSS patients presented with elevated serum levels of IL-1RA, IL-4, IL-17 and MCP compared to GC- patients.  In this follow-up study, we aimed to assess the genetic variations in GC+ and GC- pSS patients.

Methods: In a Swedish-Norwegian pSS cohort (n=540), GC+ (n=76) and GC- (n=244) patients were identified. 1536 single-nucleotide polymorphisms (SNPs) were analysed in whole blood DNA by the Illumina GoldenGate assay (Illumina Inc.). Minor allele frequencies in GC+ and GC- patients were compared using Fisher’s exact test and associations were considered significant when p<0.001 and suggestive when p<0.01. Statistical analysis were performed using the PLINK software. 

Results: In this case-only analysis of 320 pSS patients with known GC status, we identified two SNPs in Eotaxin associated with GC+ patients with OR 0.45 and 0.41. Furthermore, we found suggestive associations with BANK-1, ICA-1, IL-17, PRKCL1, CARD-8, Bcl-2, TANK, IKBKE, AID and APRIL. We also detected weak associations (p<0.05) with SNPs in the BLK, STAT1, STAT4, SSA1, SSB, IL15RA, IL-6 and TNF-a genes. Serum eotaxin (CCL11) has previously been identified as a key discriminator between GC+ and GC- pSS patients. The formation of GCs depends on B cell stimulation by helper T cells via the CD40-CD40L system, which also contribute to the expression of activation induced deaminase (AID). Genetic variations in CD40L and AID suggest that GC+ patients may be genetically predisposed for ectopic GC formation. B lymphoid kinase (BLK) has a role in the development and activation of marginal zone B cells present in the GC formations, and Bcl-2 is an anti-apoptotic protein which gene is implicated in a number of cancers and autoimmunity. CARD-8, IKBKE and TANK are regulators of the NF-κB pathway, a pathway with a well-established role in secondary lymphoid organ development.

Conclusion: Taken together, our findings suggest that genetic variations may help explain why ectopic GC-like structures are present in some pSS patients but not all


Disclosure:

T. R. Reksten,
None;

M. V. Jonsson,
None;

R. Jonsson,
None;

G. Nordmark,
None;

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2012

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-associations-to-germinal-centre-formation-in-primary-sjogrens-syndrome/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology